
When the stakes involve patient outcomes and the credibility of clinical trials in the medical, health and pharmaceutical sectors, maintaining data accuracy, integrity and privacy is essential. In ...
Early results from a pilot study into the impact of steroid-toxicity on pediatric lupus nephritis patients suggest that children experience a high burden of steroid-toxicity and that variation in ...
“Infection is probably the biggest morbidity and mortality risk early on, and steroids dramatically increase the risk of infection." Joyce Chang, MD MSCE is a pediatric rheumatologist at Boston ...
On September 4, 1948, the first dose of a glucocorticoid was administered to a bed-ridden 24-year-old woman with rheumatoid arthritis. The treatment of rheumatoid arthritis with cortisone resulted in ...
Exciting results from an open-label Phase 2 pilot trial published in Lancet Rheumatology[1] suggest that obexelimab, a potential new treatment for IgG4-related disease (IgG4-RD), may become an ...